GET A QUOTE TODAY
From August 29–31, 2025, the 21st IFOSMA & 2nd “Integration & Innovation” Joint Congress was successfully held at Ningbo Medical Center Lihuili Hospital. Recognized by ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine), IFOSMA has become one of the most influential sports medicine conferences in China, with 20 successful editions to date. The event continues to promote academic exchange, technological innovation, and the development of sports medicine worldwide.
This year’s congress attracted over 500 experts and scholars from across China and around the globe. Key topics included arthroscopy advancements, sports injury prevention and treatment, rehabilitation innovation, and medical device development, reflecting the latest frontiers of the discipline.
As a leading Chinese enterprise dedicated to designing, developing, and manufacturing sports medicine medical devices, SINOAR was invited to participate in IFOSMA 2025. At the exhibition booth, SINOAR presented its comprehensive product portfolio, including orthopedic implants, surgical instruments, and powered devices, demonstrating the company’s commitment to technological breakthroughs and clinical value.
The booth attracted a steady stream of orthopedic and sports medicine specialists. Experts engaged in in-depth discussions on design concepts, clinical applications, and innovation pathways, while also sharing valuable feedback and forward-looking requirements. These insights will guide SINOAR’s future product iterations and R&D direction.
Through its advanced engineering capabilities, strict production control, and close collaboration with clinical experts, SINOAR continues to accelerate the localization of sports medicine devices in China.
At IFOSMA 2025, the company reinforced its philosophy of being “clinical-driven and innovation-oriented.” By working hand-in-hand with frontline medical professionals, SINOAR aims to deliver safer, more precise, and more reliable solutions that empower both doctors and patients.
SINOAR will remain committed to clinical needs, continuous innovation, and global collaboration. With the mission of “Standards, Always Consistent,” the company strives to provide high-quality, cost-effective, and comprehensive sports medicine solutions, contributing to the sustainable development of China’s sports medicine field.
From August 29–31, 2025, the 21st IFOSMA & 2nd “Integration & Innovation” Joint Congress was successfully held at Ningbo Medical Center Lihuili Hospital. Recognized by ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine), IFOSMA has become one of the most influential sports medicine conferences in China, with 20 successful editions to date. The event continues to promote academic exchange, technological innovation, and the development of sports medicine worldwide.
This year’s congress attracted over 500 experts and scholars from across China and around the globe. Key topics included arthroscopy advancements, sports injury prevention and treatment, rehabilitation innovation, and medical device development, reflecting the latest frontiers of the discipline.
As a leading Chinese enterprise dedicated to designing, developing, and manufacturing sports medicine medical devices, SINOAR was invited to participate in IFOSMA 2025. At the exhibition booth, SINOAR presented its comprehensive product portfolio, including orthopedic implants, surgical instruments, and powered devices, demonstrating the company’s commitment to technological breakthroughs and clinical value.
The booth attracted a steady stream of orthopedic and sports medicine specialists. Experts engaged in in-depth discussions on design concepts, clinical applications, and innovation pathways, while also sharing valuable feedback and forward-looking requirements. These insights will guide SINOAR’s future product iterations and R&D direction.
Through its advanced engineering capabilities, strict production control, and close collaboration with clinical experts, SINOAR continues to accelerate the localization of sports medicine devices in China.
At IFOSMA 2025, the company reinforced its philosophy of being “clinical-driven and innovation-oriented.” By working hand-in-hand with frontline medical professionals, SINOAR aims to deliver safer, more precise, and more reliable solutions that empower both doctors and patients.
SINOAR will remain committed to clinical needs, continuous innovation, and global collaboration. With the mission of “Standards, Always Consistent,” the company strives to provide high-quality, cost-effective, and comprehensive sports medicine solutions, contributing to the sustainable development of China’s sports medicine field.
GET A QUOTE TODAY